$VSTS

Results: Vestis Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates

Vestis Corporation reported Q3 results, with revenue of US$662m and statutory EPS of US$0.08, which the article says was 100% above estimates. Shares were down 2.4% to US$13.52 over the past week. Analysts updated 2027 forecasts to US$2.69b revenue and US$0.53 EPS, and raised the consensus price target 18% to US$12.27.

Original reporting
Published Aug 14, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Results: Vestis Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates — source image
Decision brief

The 30-second read

$VSTSBullishLow
01

Why it matters

Analysts upgraded 2027 statutory EPS to $0.53 from $0.37 while keeping 2027 revenue near $2.69b to $2.71b, and lifted the consensus price target 18% to $12.27.

02

Market read

Traders may adjust expectations for valuation multiples based on the EPS upgrade, but the lack of revenue growth acceleration reduces conviction.

03

What to watch

Wide analyst price-target dispersion ($5.60 to $17.00) suggests high uncertainty around outcomes, which can cap follow-through on the consensus target increase.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning following the Q3 earnings and subsequent consensus estimate update

Background

The piece summarizes Vestis’ Q3 results and the subsequent consensus forecast changes for 2027.

Company-level read

Ticker impact

$VSTSBullishMedium confidence
Context

Simply Wall St reports Vestis’ Q3 results led analysts to upgrade 2027 EPS to $0.53 and raise the consensus price target 18% to $12.27.

Expected impact

Near-term bias modestly positive as the market digests the EPS upgrade and higher consensus target, but revenue forecast stability limits upside surprise.

Evidence & confidence

The article provides explicit forecast revisions (EPS up, revenue unchanged) and a sizable price-target increase, but it does not add new company fundamentals beyond the already-referenced Q3 release.

Market effects

Limited sector read-through because the article frames Vestis as expected to lag industry revenue growth.

None stated.

None stated.

Counterpoint

The EPS upgrade may be driven by accounting/statutory effects rather than durable operating improvement, since revenue forecasts are essentially unchanged and growth is expected to slow.

Key entities

  • Vestis Corporation

    Subject of the article; Q3 results and updated 2027 consensus forecasts (EPS, revenue, price target).

Related articles

$VSTSHighAI 8/10

Vestis (VSTS) Q3 2026 Earnings Call Transcript

Vestis (VSTS) reported Q3 2026 revenue of $661.7M, down 1.8% YoY due to a 4.5% volume reduction from exiting low-quality contracts. Net income was $11.0M, up from a $0.7M loss last year. Adjusted EBITDA rose 23% to $80.9M, with margins expanding to 12.2%. Free cash flow guidance was raised to $160M-$170M for the year. The company aims to reduce costs through outsourcing and asset sales.

$VSTSMed

Vestis (VSTS) Delivers Its First Real Pricing Win

Vestis (VSTS) reported Q3 results with adjusted EBITDA up 23% YoY to $81M, and revenue per pound rose for the first time since its public debut, reaching $1.42. The company improved operational metrics and raised full-year free cash flow guidance to $160M-$170M. However, total revenue fell 1.8% YoY, and net debt remains at $1.2B. Management acknowledged uneven market performance and plans to address it with customized strategies.

$VSTSMed

Why Vestis (VSTS) Stock Is Trading Up Today

Vestis (NYSE:VSTS) shares rose about 2% after the company reported fiscal Q3 results. Revenue was $661.7M, down 1.8% and below the $669.5M forecast. EPS was $0.08 versus $0.04 expected, and adjusted EBITDA was $80.9M. The company also issued upbeat full-year free cash flow guidance.

$VSTSMed

Vestis Corporation Q3 2026 Earnings Call Summary

Vestis’ Q3 2026 earnings call said revenue per pound rose year over year for the first time since IPO, aided by pricing and segmentation. The company cut volume 4.5% to exit low-quality accounts, improved plant productivity 9%, and shifted to market-specific playbooks. It raised FY2027 free cash flow guidance to $160m-$170m and FY2026 adjusted EBITDA to $310m-$315m, with Q4 $84m-$89m.

$VSTSMedAI 8/10

Vestis shares jump 8% as higher cash flow outlook offsets Q3 earnings miss

Vestis (NYSE:VSTS) shares rose about 8% premarket after the company raised its fiscal 2026 free cash flow outlook to $160 million to $170 million, up from $120 million to $150 million. Q3 adjusted EPS was $0.18 vs $0.50 expected, and revenue fell 1.8% to $661.7 million, below $834.2 million. Operating cash flow was $64.9 million.

$VSTSMed

Why Vestis (VSTS) Stock Is Trading Up Today

Vestis (NYSE: VSTS) shares rose about 2.3% after the company reported fiscal Q3 results. Revenue was $661.7 million, down 1.8% and below the $669.5 million forecast. EPS was $0.08, above the $0.04 consensus, and adjusted EBITDA was $80.9 million. The firm also issued upbeat full-year free cash flow guidance; shares later eased to $14.12.